Background: The klotho (Klt)-fibroblast growth factor-23 (FGF-23)-vitamin D axis is the main component of calcium (Ca) and phosphorus (P) metabolisms; on the contrary, it is also secreted from the choroid plexus (CP). Purpose: This study is aimed at evaluating serum soluble Klt (sKlt), FGF-23, and 25-(OH)-vitamin D levels in multiple sclerosis (MS) patients. Methods: Thirty-two relapsing-remitting MS patients (11 males and 21 females; mean age 38.3 years) and 31 age-sex matched healthy controls (12 males and 19 females; median age 38.5 years) were included in this study. All patients were diagnosed with MS according to the criteria of McDonald. Results: Serum sKlt, FGF-23, and P levels were significantly higher in MS patients compared to the control group (p < 0.01, p < 0.01, and p = 0.02, respectively). Serum 25-(OH)-vitamin D and Ca levels were significantly lower in MS patients (p < 0.01 and p = 0.04, respectively). Conclusion: Klt, which is secreted from CP, could be a response to the inflammatory condition in MS. Elevated FGF-23 levels suppress 1α-hydroxylase and upregulates 24α-hydroxylase, which results in a decrease in 1,25-(OH)2D3 levels. Thus, the neuroprotective and immunomodulatory effects of vitamin D might not be seen in MS patients.

Keywords:
Multiple sclerosis, Vitamin D, Klotho, Fibroblast growth factor-23, Choroid plexus, Demyelinization, Oligodendrocyte
1.
Tullman MJ: Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care 2013;19(2 suppl):S15-S20.
2.
Ellidag HY, Eren E, Erdogan N, et al: Comparison of neurophysiological and MRI findings of patients with multiple sclerosis using oligoclonal band technique. Ann Neurosci 2013;20:149-154.
3.
Ellidag HY, Kurtulus F, Yaman A, et al: Serum iron metabolism markers including hepcidin in multiple sclerosis patients. Neurochem J 2014;8:226-230.
4.
Aydin O, Ellidag HY, Eren E, et al: Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis. Biochem Med (Zagreb) 2014;24:383-389.
5.
Kuro-o M, Matsumura Y, Aizawa H, et al: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997;390:45-51.
6.
Nitta K, Nagano N, Tsuchiya K: Fibroblast growth factor 23/klotho axis in chronic kidney disease. Nephron Clin Pract 2014;128:1-10.
7.
Abraham CR, Chen C, Cuny GD, et al: Small-molecule klotho enhancers as novel treatment of neurodegeneration. Future Med Chem 2012;4:1671-1679.
8.
Liu H, Fergusson MM, Castilho RM, et al: Augmented Wnt signaling in a mammalian model of accelerated aging. Science 2007;317:803-806.
9.
Kuro-o M: Klotho and the aging process. Korean J Intern Med 2011;26:113-122.
10.
Sawires HK, Essam RM, Morgan MF, Mahmoud RA: Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease. Nephron 2015;129:293-299.
11.
Shimada T, Urakawa I, Yamazaki Y, et al: FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun 2004;314:409-414.
12.
Bai X, Miao D, Li J, et al: Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 2004;145:5269-5279.
13.
Donate-Correa J, Muros-de-Fuentes M, Mora-Fernández C, Navarro-González JF: FGF23/klotho axis: phosphorus, mineral metabolism and beyond. Cytokine Growth Factor Rev 2012;23:37-46.
14.
Smolders J, Menheere P, Thewissen M, et al: Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis. J Steroid Biochem Mol Biol 2010;121:243-246.
15.
Harandi AA, Harandi AA, Pakdaman H, Sahraian MA: Vitamin D and multiple sclerosis. Iran J Neurol 2014;13:1-6.
16.
Zhang HL, Wu J: Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis. Neurosci Bull 2010;26:445-454.
17.
Glade MJ: Vitamin D: health panacea or false prophet? Nutrition 2013;29:37-41.
18.
Polman CH, Reingold SC, Banwell B, et al: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
19.
Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
20.
Lee JH, Gadi R, Spertus JA, et al: Prevalence of vitamin D deficiency in patients with acute myocardial infarction. Am J Cardiol 2011;107:1636-1638.
21.
Sathyanesan M, Girgenti MJ, Banasr M, et al: A molecular characterization of the choroid plexus and stress-induced gene regulation. Transl Psychiatry 2012;2:e139.
22.
Spector R, Johanson CE: The mammalian choroid plexus. Sci Am 1989;261:68-74.
23.
Kooij G, de Vries HE: The best basic science paper in multiple sclerosis in 2014: important role for the choroid plexus in the central nervous system entry of leukocytes. Mult Scler 2015;21:372-373.
24.
Schwartz M, Baruch K: The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. EMBO J 2014;33:7-22.
25.
Wolburg H, Paulus W: Choroid plexus: biology and pathology. Acta Neuropathol 2010;119:75-88.
26.
Liebner S, Corada M, Bangsow T, et al: Wnt/beta-catenin signaling controls development of the blood-brain barrier. J Cell Biol 2008;183:409-417.
27.
Liebner S, Czupalla CJ, Wolburg H: Current concepts of blood-brain barrier development. Int J Dev Biol 2011;55:467-476.
28.
Clinton SM, Glover ME, Maltare A, et al: Expression of klotho mRNA and protein in rat brain parenchyma from early postnatal development into adulthood. Brain Res 2013;1527:1-14.
29.
Chen CD, Li H, Liang J, et al: The anti-aging and tumor suppressor protein klotho enhances differentiation of a human oligodendrocytic hybrid cell line. J Mol Neurosci 2015;55:76-90.
30.
Reuss B, Dono R, Unsicker K: Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglial differentiation and blood-brain barrier permeability: evidence from mouse mutants. J Neurosci 2003;23:6404-6412.
31.
Zhang X, Bao L, Yang L, et al: Roles of intracellular fibroblast growth factors in neural development and functions. Sci China Life Sci 2012;55:1038-1044.
32.
Muthian G, Raikwar HP, Rajasingh J, et al: 1,25 dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis. J Neurosci Res 2006;83:1299-1309.
33.
Zhang X, Jin J, Tang Y, et al: IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation. J Immunol 2009;182:3928-3936.
34.
DeLuca GC, Kimball SM, Kolasinski J, et al: Review: the role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol 2013;39:458-484.
35.
Shirazi HA, Rasouli J, Ciric B, et al: 1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation. Exp Mol Pathol 2015;98:240-245.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.